anubhai
Back OfficeNippon India Pharma Fund (G)
Summary
| Fund Name | Nippon India Mutual Fund |
| Scheme Name | Nippon India Pharma Fund (G) |
| AMC | Nippon India Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 10-May-2004 |
| Fund Manager | Sailesh Raj Bhan |
| Net Assets(Rs. cr) | 9,166.40 |
NAV Graph
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 4.53 | -0.11 | -2.12 | 7.85 | 8.91 | 17.45 | 13.04 | 19.64 |
| Category Avg | 4.82 | 0.12 | -1.04 | 12.84 | 13.85 | 21.21 | 14.77 | 15.37 |
| Category Best | 6.47 | 1.65 | 1.69 | 19.58 | 24.62 | 30.41 | 18.89 | 29.25 |
| Category Worst | 3.76 | -1.35 | -5.07 | 2.48 | 0.16 | 15.82 | 11.66 | -3.20 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 11.71 |
| Divi's Lab. | 7.10 |
| Lupin | 6.17 |
| Cipla | 6.01 |
| Dr Reddy's Labs | 5.45 |
| Apollo Hospitals | 4.89 |
| Mankind Pharma | 4.38 |
| Sai Life | 3.92 |
| Ajanta Pharma | 3.61 |
| Glaxosmi. Pharma | 3.11 |
| Ipca Labs. | 2.87 |
| Max Healthcare | 2.70 |
| Vijaya Diagnost. | 2.62 |
| Medplus Health | 2.53 |
| Gland Pharma | 2.53 |
| Abbott India | 2.32 |
| Piramal Pharma | 2.24 |
| Thyrocare Tech. | 2.24 |
| Dr Lal Pathlabs | 2.17 |
| Alkem Lab | 1.82 |
| Aurobindo Pharma | 1.65 |
| Narayana Hrudaya | 1.61 |
| Suraksha Diagno. | 1.51 |
| Syngene Intl. | 1.40 |
| Emcure Pharma | 1.36 |
| Pfizer | 1.35 |
| Akums Drugs | 1.21 |
| Anthem Bioscienc | 1.19 |
| Fortis Health. | 1.13 |
| Biocon | 1.01 |
| Sanofi India | 1.00 |
| Sanofi Consumer | 0.89 |
| Molbio Diagnosti | 0.54 |
| Indoco Remedies | 0.48 |
| Astrazeneca Phar | 0.42 |
| Concord Biotech | 0.17 |
| TREPS | 2.81 |
| Net CA & Others | -0.14 |
| C C I | 0.02 |
